Thursday broker round-up
11th Feb 2016 13:52
(ShareCast News) - ARM Holdings: JP Morgan reiterates neutral with a target of 950p, Exane BNP Paribas keeps at outperform, 1300p target, Deutsche Bank stays at hold, 1000p target, Goldman Sachs maintains buy with a target of 1400p, Citigroup keeps at neutral and Bryan, Garnier & Co reiterates buy.
Read moreBroker tips: Smith & Nephew, Pennon, Halma
11th Feb 2016 11:55
(ShareCast News) - Smith & Nephew shares plunged on Thursday after UBS downgraded the company to 'neutral' on concerns about margin expansion. The investment bank said in a note that it has previously rated the company at 'buy' on the opportunity for margin expansion driven by a recovery in the Woun
Read moreUBS cuts Smith & Nephew rating on margin expansion concerns
11th Feb 2016 10:13
(ShareCast News) - Smith & Nephew shares plunged on Thursday after UBS downgraded the company to 'neutral' on concerns about margin expansion. The investment bank said in a note that it has previously rated the company at 'buy' on the opportunity for margin expansion driven by a recovery in the Woun
Read moreThursday broker round-up
4th Feb 2016 16:07
(ShareCast News) - Coca-Cola HBC: Barclays downgrades to underweight with a target of 1325p. TalkTalk: Goldman Sachs downgrades to neutral with a target of 271p. Paragon Group: JP Morgan downgrades to neutral and sets a 380p target. Antofagasta: Investec reiterates sell with a target of 305p. Ang
Read moreSmith and Nephew revenue flat while full year profit dips
4th Feb 2016 08:05
(ShareCast News) - Smith & Nephew's full year revenue has remained flat for the year to 31 December 2015, while reported operating profit dipped. The FTSE 100 medical device company said full year revenue was $4.634bn (£3.172bn), flat compared to 2014's revenue of $4.617bn. Underlying growth was 5%
Read moreSmith & Nephew CEO diagnosed with cancer
1st Feb 2016 07:35
(ShareCast News) - Smith & Nephew's chief executive officer Olivier Bohuon has been diagnosed with cancer, it was revealed on Monday. The FTSE 100 medical technology firm described the form of cancer as "highly treatable", and said Bohuon would remain chief executive officer and be actively involved
Read moreSmith & Nephew completes acquisition of surgical robotics business
5th Jan 2016 07:09
(ShareCast News) - Medical tech business Smith & Nephew has completed the acquisition of surgical robotics business Blue Belt Technologies. The FTSE 100 company announced the completion of the deal on Monday, which was originally announced in October last year. It said the deal, which is valued at
Read moreLondon pre-open: Stocks seen higher as Asia stabilises
5th Jan 2016 07:07
(ShareCast News) - London stocks are set to open higher on Tuesday on the back of a stabilisation in Asian markets following heavy losses in the previous session. The FTSE 100 is expected to start 49 points higher than Monday's close at 6,142. "After an initial wobble, shares in Shanghai and Shenzh
Read moreUS-based Stryker set to pounce on Smith&Nephew
18th Dec 2015 16:07
(ShareCast News) - Stryker may be set to pounce on rival Smith&Nephew according to a person with knowledge of the situation, Street Insider reported. Although rumours about just such a transaction had been percolating through markets for a long time, they had not lost their power to influence the sh
Read moreFriday broker round-up
30th Oct 2015 10:19
(ShareCast News) - Barclays: Goldman Sachs reiterates to buy. Target price: 335.00p. Bt Group: Citigroup reiterates to neutral. Target price: 485.00p. Smith & Nephew: Credit Suisse reiterates to neutral, cuts target price to 1105.00p. Henderson Group: Citigroup reiterates to buy, keeps target pric
Read moreSmith & Nephew slumps as third-quarter revenue misses estimates
29th Oct 2015 08:03
(ShareCast News) - Smith & Nephew fell after its third-quarter revenue came in a little weaker than expected, as the maker of artificial hips and knees maintained its full-year guidance and announced the acquisition of robotics company Blue Belt Technologies. For the quarter ended 26 September, the
Read moreBroker tips: WANdisco, Smith & Nephew, Great Portland
31st Jul 2015 16:44
(ShareCast News) - UBS reiterated its 'buy' recommendation on 'big data' software company WANdisco but slashed its target price by more than half to 330p, though this still offered a 69% upside on Thursday's closing price. Sheffield-based WANdisco reported second-quarter bookings of $2.4m, down 29%
Read moreCharles Stanley upgrades Smith & Nephew to 'accumulate' off quarter two results
31st Jul 2015 15:01
(ShareCast News) - Analysts at Charles Stanley raised their rating for Smith & Nephew from 'hold' to 'accumulate' and lifted their price target to 1167p from 1143p. Medical products suppler Smith & Nephew posted revenue up by 5% to $1,168m and trading profit up 6% to $512m. Charles Stanley analyst
Read moreFTSE 100 movers: Shell rallies on better-than-expected earnings, but Centrica drops after announcing job cuts
30th Jul 2015 15:56
(ShareCast News) - London's top-flight index was up 0.6% at 6,670 by 15:41 BST, as investors waded through a raft of earnings reports. Royal Dutch Shell and BG Group were both sharply higher after Shell's second-quarter results beat expectations. The Anglo-Dutch oil major posted adjusted profits of
Read moreSmith & Nephew first-half profit rises, reiterates full-year guidance
30th Jul 2015 08:53
(ShareCast News) - Smith & Nephew posted a 4% rise in first-half revenue and a 6% gain in underlying trading profit amid continued improvement in its Advanced Wound Care business, growth in emerging markets and a strong global performance in its reconstruction unit. Revenue for the first half ended
Read more